Ask Warren

Cell Biotech

049960 · KOSDAQ · ₩049960 · 쎌바이오텍

₩14,800▼ ₩30 (0.20%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩16B₩15B₩15B₩15B₩12B₩11B₩12B₩12B
Cost of sales₩4.2B₩3.9B₩3.9B₩4.3B₩3B₩3.2B₩3.3B₩3.5B
Gross profit₩12B₩11B₩11B₩11B₩8.9B₩8B₩8.8B₩8.7B
Operating income₩1.6B₩3.2B₩3.1B₩2.2B₩1.3B₩1.4B₩1.1B₩2.1B
Net income−₩1.7B₩5.4B₩6.7B₩3.2B−₩1.9B₩2.1B₩14B−₩3.1B
Net income to shareholders₩3.6B₩5.4B₩4.4B₩3.4B₩213M₩2.1B₩6.9B₩969M

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩145B₩143B₩137B₩135B₩130B₩133B₩130B₩123B
Current assets₩110B₩107B₩104B₩101B₩97B₩100B₩97B₩89B
Cash and equivalents₩28B₩27B₩17B₩15B₩8.1B₩18B₩4.8B₩13B
Total liabilities₩8.2B₩10B₩4.9B₩7.5B₩6.1B₩9.3B₩6.2B₩6B
Current liabilities₩8.1B₩10B₩4.9B₩7.4B₩5.9B₩9B₩5.9B₩5.5B
Total equity₩137B₩133B₩132B₩127B₩123B₩123B₩124B₩117B
Shareholders' equity₩137B₩133B₩132B₩127B₩123B₩123B₩124B₩117B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩6B₩3.7B₩4.2B₩4.1B₩1.2B₩1.6B₩4.7B₩3.5B
Capital spending₩460M₩4.2B₩285M₩2.3B₩454M₩97M₩416M₩258M
Free cash flow₩5.6B−₩531M₩3.9B₩1.9B₩719M₩1.5B₩4.3B₩3.2B
Dividends paid₩0₩4.1B₩0₩0₩0₩3.1B₩0₩0

Consolidated where available. Amounts in won.

Also known as: Cell Biotech / 쎌바이오텍 / 049960 / KRX:049960

Source: KRX statistical information